← Evidence library

BIB_172

Carvajal RD / Nathan P et al. Tebentafusp (gp100×CD3 BiTE) in untreated metastatic uveal melanoma. NEJM 2021;385(13):1196–1206. PMID 34551219. First successful BiTE in solid tumour; HLA-A02:01-restricted; uveal-specific. [Tasks: 17, 18] Tier: 1 Grade: A Retrieved: 2026-05-07

Evidence grade

A

Tier

1

Cited by tasks

17, 18

Identifiers

PMID:34551219

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_172/findings.md (research corpus). This page is a short context summary — not individualised medical advice.